ADI vs AUTL · P/E 61, rev $11.02B vs rev $71.9M
Analog Devices Inc (ADI) versus Autolus Therapeutics Ltd (AUTL) — a side-by-side from cached financials, not a winner call.
Analog Devices Inc (ADI) is a semiconductors company listed on NASDAQ.
Autolus Therapeutics Ltd (AUTL) is a biotechnology company listed on US.
Latest reported ADI revenue for 2025-11-01 was $11.02B. Net income was $2.27B. ADI currently screens at market cap $201.87B and trailing P/E 61.5.
Latest reported AUTL revenue for 2026-06-30 was $71.9M. Net income was -$110.7M. AUTL currently screens at market cap $614.8M.
ADI currently screens at market cap $201.87B and trailing P/E 61.5. AUTL currently screens at market cap $614.8M.
Not investment advice. Open the ADI and AUTL stock pages for the full models.
Not investment advice.